SEI Investments
FLXN

SEI Investments’s Flexion Therapeutics, Inc. FLXN Stock Holding History

SEI Investments’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-43,737
Closed -$360K – 2679
2021
Q2 		$360K Buy
+43,737
New +$372K ﹤0.01% 2246
2021
Q1 		– Sell
-35,767
Closed -$413K – 2540
2020
Q4 		$413K Sell
35,767
-22
-0.1% -$256 ﹤0.01% 2072
2020
Q3 		$373K Sell
35,789
-905
-2% -$11.1K ﹤0.01% 2019
2020
Q2 		$483K Buy
36,694
+1,442
+4% +$15K ﹤0.01% 1867
2020
Q1 		$277K Buy
35,252
+586
+2% +$8.83K ﹤0.01% 1978
2019
Q4 		$718K Sell
34,666
-8,896
-20% -$150K ﹤0.01% 1777
2019
Q3 		$597K Buy
43,562
+526
+1% +$6.24K ﹤0.01% 1799
2019
Q2 		$529K Buy
43,036
+16,774
+64% +$194K ﹤0.01% 1852
2019
Q1 		$328K Sell
26,262
-2,339
-8% -$31.3K ﹤0.01% 2085
2018
Q4 		$535K Hold
28,601
– – ﹤0.01% 1732
2018
Q3 		$535K Sell
28,601
-9,567
-25% -$220K ﹤0.01% 1643
2018
Q2 		$987K Buy
38,168
+36,105
+1,750% +$937K ﹤0.01% 1594
2018
Q1 		$46K Sell
2,063
-500
-20% -$12.2K ﹤0.01% 2388
2017
Q4 		$65K Buy
2,563
+2,063
+413% +$50.5K ﹤0.01% 2271
2017
Q3 		$12K Hold
500
– – ﹤0.01% 2655
2017
Q2 		$10K Hold
500
– – ﹤0.01% 2593
2017
Q1 		$13K Hold
500
– – ﹤0.01% 2418
2016
Q4 		$10K Hold
500
– – ﹤0.01% 2476
2016
Q3 		$10K Buy
+500
New +$8.46K ﹤0.01% 2410

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SEI Investments's FLXN Position: Q3 2021 in Review

SEI Investments sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2021, closing a stake of 43,737 shares — an estimated $360K sold.

SEI Investments first reported a position in FLXN in Q3 2016 and held it in 19 quarters. The position peaked at $987K in Q2 2018. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

  • SEI Investments reported no remaining Flexion Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • SEI Investments sold 43,737 Flexion Therapeutics, Inc. shares in Q3 2021, an estimated $360K.
  • SEI Investments first reported a position in Flexion Therapeutics, Inc. in Q3 2016 and held it in 19 quarters.
  • SEI Investments's Flexion Therapeutics, Inc. position peaked at $987K in Q2 2018.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on SEI Investments's 13F filing for Q3 2021, filed 12 Nov 2021.